Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The ...

Virtual Meeting to be held on February 20 hosted by BTIG.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

DexCom Inc. closed 39.17% below its 52-week high of $142.00, which the company reached on March 26th.

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. Vandana Singh Stocks Head For ...

Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...

Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...

On Thursday, Dexcom, Inc.'s (NASDAQ:DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus estimate of $1.104 billion. U.S. revenue rose by 4% ...

Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin) to ...

Shares of DexCom Inc. DXCM slid 2.91% to $83.87 Wednesday, on what proved to be an all-around poor trading session for the ...